Absence of differences in the recurrence rates of hepatitis C virus‑associated hepatocellular carcinoma between direct‑acting antivirals and interferon‑based treatments: A multicenter study | Zendy

Atsushi Nakazawa | Zendy; Shinichi Fujioka | Zendy; Kazuo Notsumata | Zendy; Toshihide Shima | Zendy; Kimihiko Yangita | Zendy; Masanori Kawaguchi | Zendy; Toshiyuki Tahara | Zendy; Masaki Oomoto | Zendy; Toru Ishikawa | Zendy; Ichiro Kawana | Zendy; Nobuhiro Tsukada | Zendy; Shinsuke Funakoshi | Zendy; Ito H | Zendy; Tomoo Nagano | Zendy; Yutaka Horie | Zendy; Masayuki Tatemichi | Zendy; Kazuhide Yamamoto | Zendy; Takeshi Okanoue | Zendy

Open Access

Absence of differences in the recurrence rates of hepatitis C virus‑associated hepatocellular carcinoma between direct‑acting antivirals and interferon‑based treatments: A multicenter study

Author(s) -

Atsushi Nakazawa,

Shinichi Fujioka,

Kazuo Notsumata,

Toshihide Shima,

Kimihiko Yangita,

Masanori Kawaguchi,

Toshiyuki Tahara,

Masaki Oomoto,

Toru Ishikawa,

Ichiro Kawana,

Nobuhiro Tsukada,

Shinsuke Funakoshi,

Ito H,

Tomoo Nagano,

Yutaka Horie,

Masayuki Tatemichi,

Kazuhide Yamamoto,

Takeshi Okanoue

Publication year - 2021

Publication title -

world academy of sciences journal

Language(s) - English

Resource type - Journals

eISSN - 2632-2919

pISSN - 2632-2900

DOI - 10.3892/wasj.2021.98

Subject(s) - hepatocellular carcinoma , medicine , propensity score matching , confounding , gastroenterology , regimen , hepatitis c virus , interferon , proportional hazards model , hepatitis c , oncology , virus , immunology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research